drugset / Trial / NCT05362695
A Study of Multiple-ascending Doses of IW-3300 in Healthy Subjects
RandomizedSequentialTriple-blindTreatment
Summary
This clinical study is designed as a multiple-ascending-dose, safety and tolerability study with IW-3300. The study drug will be administered as a low-volume \[20 mL\] enema. Study participants will be randomized in a 2:1 ratio to receive IW-3300 or placebo. Up to 3 different doses of IW-3300 will be studied. Safety reviews will be conducted before proceeding to each higher dose.
Timeline
- Start
- 2022-05-17
- Primary completion
- 2022-06-30
- Completion
- 2022-07-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IW-3300 | Unknown | 100 ug | Other |
| Subject | IW-3300 | Unknown | 300 ug | Other |
Indications
No indication recorded.